SYSTEMIC AMYLOIDOSIS IN PATIENT WITH GOUT
- Authors: Voloshinova EV1, Lobanova OS1, Nikitina NM1
-
Affiliations:
- Issue: No 1 (2011)
- Pages: 78-79
- Section: Articles
- URL: https://journals.eco-vector.com/2075-3594/article/view/245989
- ID: 245989
Cite item
Full Text
Abstract
Rare case of development of secondary amyloidosis in chronic gout is described; differential diagnosis of chronic arthritis, associated with kidney involvement, is discussed
Keywords
References
- Merlin G., Bellotti V. Molecular Mechanisms of Amyloidosis. N. Engl. J. Med. 2003; 349: 583-596.
- Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee. Bull World Health Organ 1993; 71(1):105-12.
- Ahlmen M., Ahlmen J., Svalander C., Bucht H. Cytotoxic drug treatment of reactive amyloidosis in rheumatoid arthritis with special reference to renal insufficiency. Clin Rheumatol 1987; 6(1): 27-38.
- Мухин Н.А. Клинические проблемы амилоидоза почек. Клин мед 1983; 61(10):12-17.
- Levo Y., Shalev O., Rosenmann E., et al. Gout and amyloidosis. Ann Rheum Dis 1980; 39: 589-591
Supplementary files
